Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:1667-1672
Published online before print June 5, 2003, doi: 10.1161/01.STR.0000075293.45936.FA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/7/1667    most recent
01.STR.0000075293.45936.FAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cantu, C.
Right arrow Articles by Barinagarrementeria, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantu, C.
Right arrow Articles by Barinagarrementeria, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-EPHEDRINE
*OXYMETAZOLINE
*PHENYLPROPANOLAMINE
*PSEUDOEPHEDRINE
Medline Plus Health Information
*Over-the-Counter Medicines
*Stroke
Related Collections
Right arrow Vasculitis Brain Arteries
Right arrow Acute Cerebral Hemorrhage
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:1667.)
© 2003 American Heart Association, Inc.


Original Contributions

Stroke Associated With Sympathomimetics Contained in Over-the-Counter Cough and Cold Drugs

Carlos Cantu, MD, MSc; Antonio Arauz, MD, MSc; Luis M. Murillo-Bonilla, MD; Mario López, MD Fernando Barinagarrementeria, MD

From the Stroke Clinic, National Institute of Neurology and Neurosurgery, Tlalpan, Mexico.

Correspondence to Carlos Cantu, MD, Stroke Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, DF Mexico PC 14269. E-mail carloscantu_brito{at}hotmail.com

Background and Purpose— Phenylpropanolamine (PPA) and pseudoephedrine are sympathomimetics contained in over-the-counter cold preparations. A case-control study linked PPA use with hemorrhagic stroke in women. Twenty-two patients with stroke associated with use of these drugs are described.

Methods— In a consecutive stroke registry since 1988, 22 patients had stroke associated with over-the-counter sympathomimetics. Sympathomimetic dosage and type, time interval until stroke onset, and neuroimaging findings are described.

Results— Ten male and 12 female patients were included. Intracerebral hemorrhage occurred in 17 patients, subarachnoid hemorrhage in 4, and ischemic stroke in 1. Stroke was associated with PPA use in 16 patients (dose 75 to 675 mg), with pseudoephedrine in 4 (dose 60 to 300 mg), and with others administered by the nasal route in 2 (oxymetazoline and phenylephrine). Stroke occurred after a single dose in 17 patients and after daily use during several days in 5. The interval between drug exposure and clinical onset varied from 30 minutes to 24 hours. Stroke occurred after recommended doses of PPA (50 to 75 mg) in 32% and pseudoephedrine (60 mg) in 50% of patients. Eight patients had acute hypertension at stroke onset. Cerebral angiography was normal in 8 cases and showed diffuse vasospasm or beading in 10 patients.

Conclusions— Stroke related to over-the-counter sympathomimetics was associated with acute hypertension and/or vasospasm or angiitis mechanisms, most related to the use of PPA; however, stroke also occurred with the use of other sympathomimetics, particularly pseudoephedrine. Although stroke complications occurred when doses were used that were higher than recommended doses, apparently there is also a stroke risk when these agents are taken properly.


Key Words: phenylpropanolamine • stroke • sympathomimetics




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R R Moustafa, C M C Allen, and J-C Baron
Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases
J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 602 - 605.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Ducros, M. Boukobza, R. Porcher, M. Sarov, D. Valade, and M.-G. Bousser
The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
Brain, December 1, 2007; 130(12): 3091 - 3101.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Kurth, C. Cantu, A. Arauz, L. Murillo-Bonilla, and F. Barinagarrementeria
Over-the-Counter Cough and Cold Medication Use and Risk of Stroke * Response
Stroke, December 1, 2003; 34 (12): e234 - e235.
[Full Text] [PDF]


Home page
StrokeHome page
J. C.M. Brust
Editorial Comment--Over-the-Counter Cold Remedies and Stroke
Stroke, July 1, 2003; 34(7): 1673 - 1673.
[Full Text] [PDF]